CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...

CVS Caremark has been ordered to pay $95 million after a federal judge found the pharmacy benefit manager improperly inflated Medicare Part D drug prices by failing to report required pharmacy ...

CVS Health’s pharmacy benefit manager, Caremark, has been ordered to pay $95 million for overbilling Medicare Part D drug reimbursements, a federal judge ruled Wednesday — a decision that could ...

CVS Health and its subsidiaries have experienced a turbulent week in the courts. | Not long after the state of Louisiana sued ...

Investing.com -- A federal judge ordered CVS Health (NYSE: CVS)’s pharmacy benefit manager unit to pay $95 million to the U.S. government for overcharging Medicare for prescription drugs.

A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for ...

A U.S. federal judge has ordered CVS Caremark, the pharmacy benefits arm of CVS Health, to pay $95 million over allegations ...

Check out our CVS stock chart to see a history of performance, current stock value, ... CVS Health Corp CVS. Stock XNYS Rating as of Jun 27, 2025. Read Company Report Download PDF.

Review the current CVS Health Corp (CVS:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if CVS is the best investment for you.